Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.

Mitrofanova A, Mallela SK, Ducasa GM, Yoo TH, Rosenfeld-Gur E, Zelnik ID, Molina J, Varona Santos J, Ge M, Sloan A, Kim JJ, Pedigo C, Bryn J, Volosenco I, Faul C, Zeidan YH, Garcia Hernandez C, Mendez AJ, Leibiger I, Burke GW, Futerman AH, Barisoni L, Ishimoto Y, Inagi R, Merscher S, Fornoni A.

Nat Commun. 2019 Jun 19;10(1):2692. doi: 10.1038/s41467-019-10584-4.

2.

Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome.

Cho ME, Branton MH, Smith DA, Bartlett L, Howard L, Reynolds JC, Rosenstein D, Sethi S, Nava MB, Barisoni L, Fervenza FC, Kopp JB.

Am J Nephrol. 2019;49(5):377-385. doi: 10.1159/000497064. Epub 2019 Apr 9.

PMID:
30965344
3.

Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial.

Schiffmann R, Goker-Alpan O, Holida M, Giraldo P, Barisoni L, Colvin RB, Jennette CJ, Maegawa G, Boyadjiev SA, Gonzalez D, Nicholls K, Tuffaha A, Atta MG, Rup B, Charney MR, Paz A, Szlaifer M, Alon S, Brill-Almon E, Chertkoff R, Hughes D.

J Inherit Metab Dis. 2019 May;42(3):534-544. doi: 10.1002/jimd.12080. Epub 2019 Apr 8.

PMID:
30834538
4.

Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.

Germain DP, Nicholls K, Giugliani R, Bichet DG, Hughes DA, Barisoni LM, Colvin RB, Jennette JC, Skuban N, Castelli JP, Benjamin E, Barth JA, Viereck C.

Genet Med. 2019 Feb 6. doi: 10.1038/s41436-019-0451-z. [Epub ahead of print]

PMID:
30723321
5.

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.

Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM; CureGN Consortium.

Am J Kidney Dis. 2019 Feb;73(2):218-229. doi: 10.1053/j.ajkd.2018.07.020. Epub 2018 Nov 9.

PMID:
30420158
6.

Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial.

Schiffmann R, Bichet DG, Jovanovic A, Hughes DA, Giugliani R, Feldt-Rasmussen U, Shankar SP, Barisoni L, Colvin RB, Jennette JC, Holdbrook F, Mulberg A, Castelli JP, Skuban N, Barth JA, Nicholls K.

Orphanet J Rare Dis. 2018 Apr 27;13(1):68. doi: 10.1186/s13023-018-0813-7.

7.

Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring System.

Zee J, Hodgin JB, Mariani LH, Gaut JP, Palmer MB, Bagnasco SM, Rosenberg AZ, Hewitt SM, Holzman LB, Gillespie BW, Barisoni L.

Arch Pathol Lab Med. 2018 May;142(5):613-625. doi: 10.5858/arpa.2017-0181-OA. Epub 2018 Feb 19.

8.

Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.

Hommos MS, Zeng C, Liu Z, Troost JP, Rosenberg AZ, Palmer M, Kremers WK, Cornell LD, Fervenza FC, Barisoni L, Rule AD.

Kidney Int. 2018 May;93(5):1175-1182. doi: 10.1016/j.kint.2017.09.028. Epub 2017 Dec 19.

9.

Digital pathology in nephrology clinical trials, research, and pathology practice.

Barisoni L, Hodgin JB.

Curr Opin Nephrol Hypertens. 2017 Nov;26(6):450-459. doi: 10.1097/MNH.0000000000000360. Review.

10.

APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.

Madhavan SM, O'Toole JF, Konieczkowski M, Barisoni L, Thomas DB, Ganesan S, Bruggeman LA, Buck M, Sedor JR.

JCI Insight. 2017 Jul 20;2(14). pii: 92581. doi: 10.1172/jci.insight.92581. eCollection 2017 Jul 20.

11.

Digital pathology imaging as a novel platform for standardization and globalization of quantitative nephropathology.

Barisoni L, Gimpel C, Kain R, Laurinavicius A, Bueno G, Zeng C, Liu Z, Schaefer F, Kretzler M, Holzman LB, Hewitt SM.

Clin Kidney J. 2017 Apr;10(2):176-187. doi: 10.1093/ckj/sfw129. Epub 2017 Feb 18.

12.

Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.

Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien HP, Zee J, Smith A, Appel GB, Trachtman H, Hewitt SM, Kretzler M, Bagnasco SM.

Nephrol Dial Transplant. 2018 Feb 1;33(2):310-318. doi: 10.1093/ndt/gfw443.

13.

Erratum: A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis.

Berera S, Gomez A, Dholaria K, Arosemena LR, Ladino-Avellaneda MA, Barisoni L, Bhamidimarri KR.

ACG Case Rep J. 2017 Feb 15;4:e26. doi: 10.14309/crj.2017.26. eCollection 2017. No abstract available.

14.

A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis.

Berera S, Gomez A, Dholaria K, Arosemena LR, Ladino-Avellaneda MA, Barisoni L, Bhamidimarri KR.

ACG Case Rep J. 2016 Sep 28;3(4):e134. eCollection 2016 Aug. Erratum in: ACG Case Rep J. 2017 Feb 15;4:e26.

15.

The Application of Digital Pathology to Improve Accuracy in Glomerular Enumeration in Renal Biopsies.

Rosenberg AZ, Palmer M, Merlino L, Troost JP, Gasim A, Bagnasco S, Avila-Casado C, Johnstone D, Hodgin JB, Conway C, Gillespie BW, Nast CC, Barisoni L, Hewitt SM.

PLoS One. 2016 Jun 16;11(6):e0156441. doi: 10.1371/journal.pone.0156441. eCollection 2016.

16.

Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations.

Lemley KV, Bagnasco SM, Nast CC, Barisoni L, Conway CM, Hewitt SM, Song PX.

PLoS One. 2016 Jun 10;11(6):e0157148. doi: 10.1371/journal.pone.0157148. eCollection 2016.

17.

Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images.

Barisoni L, Troost JP, Nast C, Bagnasco S, Avila-Casado C, Hodgin J, Palmer M, Rosenberg A, Gasim A, Liensziewski C, Merlino L, Chien HP, Chang A, Meehan SM, Gaut J, Song P, Holzman L, Gibson D, Kretzler M, Gillespie BW, Hewitt SM.

Mod Pathol. 2016 Jul;29(7):671-84. doi: 10.1038/modpathol.2016.58. Epub 2016 Apr 22.

18.

APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.

Bruggeman LA, Wu Z, Luo L, Madhavan SM, Konieczkowski M, Drawz PE, Thomas DB, Barisoni L, Sedor JR, O'Toole JF.

J Am Soc Nephrol. 2016 Dec;27(12):3600-3610. Epub 2016 Mar 29.

19.

Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

Ju W, Nair V, Smith S, Zhu L, Shedden K, Song PXK, Mariani LH, Eichinger FH, Berthier CC, Randolph A, Lai JY, Zhou Y, Hawkins JJ, Bitzer M, Sampson MG, Thier M, Solier C, Duran-Pacheco GC, Duchateau-Nguyen G, Essioux L, Schott B, Formentini I, Magnone MC, Bobadilla M, Cohen CD, Bagnasco SM, Barisoni L, Lv J, Zhang H, Wang HY, Brosius FC, Gadegbeku CA, Kretzler M; ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium.

Sci Transl Med. 2015 Dec 2;7(316):316ra193. doi: 10.1126/scitranslmed.aac7071.

20.

Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes.

Nast CC, Lemley KV, Hodgin JB, Bagnasco S, Avila-Casado C, Hewitt SM, Barisoni L.

Semin Nephrol. 2015 May;35(3):266-78. doi: 10.1016/j.semnephrol.2015.04.006. Review.

21.

Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.

Sampson MG, Robertson CC, Martini S, Mariani LH, Lemley KV, Gillies CE, Otto EA, Kopp JB, Randolph A, Vega-Warner V, Eichinger F, Nair V, Gipson DS, Cattran DC, Johnstone DB, O'Toole JF, Bagnasco SM, Song PX, Barisoni L, Troost JP, Kretzler M, Sedor JR; Nephrotic Syndrome Study Network.

J Am Soc Nephrol. 2016 Mar;27(3):814-23. doi: 10.1681/ASN.2014111131. Epub 2015 Jul 6.

22.

Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1.

Lee K, Boctor S, Barisoni LM, Gusella GL.

J Am Soc Nephrol. 2015 Apr;26(4):888-95. doi: 10.1681/ASN.2013111179. Epub 2014 Aug 21.

23.

Diabetic nephropathy: Is it time yet for routine kidney biopsy?

Gonzalez Suarez ML, Thomas DB, Barisoni L, Fornoni A.

World J Diabetes. 2013 Dec 15;4(6):245-55. doi: 10.4239/wjd.v4.i6.245. Review.

24.

Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.

Rangel ML, Alghamdi I, Contreras G, Harrington T, Thomas DB, Barisoni L, Andrews D, Wolf M, Asif A, Nayer A.

Lupus. 2013 Jul;22(8):855-64. doi: 10.1177/0961203313491024. Epub 2013 May 30.

PMID:
23722230
25.

Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE).

Barisoni L, Nast CC, Jennette JC, Hodgin JB, Herzenberg AM, Lemley KV, Conway CM, Kopp JB, Kretzler M, Lienczewski C, Avila-Casado C, Bagnasco S, Sethi S, Tomaszewski J, Gasim AH, Hewitt SM.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1449-59. doi: 10.2215/CJN.08370812. Epub 2013 Feb 7.

26.

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.

Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M.

Kidney Int. 2013 Apr;83(4):749-56. doi: 10.1038/ki.2012.428. Epub 2013 Jan 16.

27.

Safety and pharmacodynamic effects of a pharmacological chaperone on α-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies.

Germain DP, Giugliani R, Hughes DA, Mehta A, Nicholls K, Barisoni L, Jennette CJ, Bragat A, Castelli J, Sitaraman S, Lockhart DJ, Boudes PF.

Orphanet J Rare Dis. 2012 Nov 24;7:91. doi: 10.1186/1750-1172-7-91.

28.

Regarding Maas's editorial letter on serum suPAR levels.

Trachtman H, Gipson DS, Kaskel F, Ghiggeri GM, Faul C, Gupta V, Fornoni A, Burke GW 3rd, Thomas DB, Barisoni L, Schaefer F, Wei C, Reiser J.

Kidney Int. 2012 Aug;82(4):492. doi: 10.1038/ki.2012.230. No abstract available.

29.

Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy.

Surindran S, Ayalon R, Hasan N, Beck LH Jr, Salant DJ, Barisoni L, Skolnik EY, Beara-Lasic L.

Clin Kidney J. 2012 Apr;5(2):162-165. Epub 2012 Mar 9.

30.

Novel quantitative method to evaluate globotriaosylceramide inclusions in renal peritubular capillaries by virtual microscopy in patients with fabry disease.

Barisoni L, Jennette JC, Colvin R, Sitaraman S, Bragat A, Castelli J, Walker D, Boudes P.

Arch Pathol Lab Med. 2012 Jul;136(7):816-24. doi: 10.5858/arpa.2011-0350-OA. Erratum in: Arch Pathol Lab Med. 2012 Jul;136(7):842.

PMID:
22742555
31.

Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.

Salvatore SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV.

Clin J Am Soc Nephrol. 2012 Jun;7(6):914-25. doi: 10.2215/CJN.11751111. Epub 2012 Mar 29.

32.

Podocyte biology in segmental sclerosis and progressive glomerular injury.

Barisoni L.

Adv Chronic Kidney Dis. 2012 Mar;19(2):76-83. doi: 10.1053/j.ackd.2012.02.018. Review.

PMID:
22449344
33.

Glomerular grievances and CKD.

Nast CC, Barisoni L.

Adv Chronic Kidney Dis. 2012 Mar;19(2):59-60. doi: 10.1053/j.ackd.2012.02.012. No abstract available.

PMID:
22449341
34.

Dysregulation of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis.

Izmirly PM, Shvartsbeyn M, Meehan S, Franks A, Braun A, Ginzler E, Xu SX, Yee H, Rivera TL, Esmon C, Barisoni L, Merrill JT, Buyon JP, Clancy RM.

J Rheumatol. 2012 Mar;39(3):510-5. doi: 10.3899/jrheum.110878. Epub 2012 Feb 1. Erratum in: J Rheumatol. 2012 Apr;39(4):881. Rivera, Tania [corrected to Rivera, Tania L].

35.

Quantitative evaluation of acute renal transplant dysfunction with low-dose three-dimensional MR renography.

Yamamoto A, Zhang JL, Rusinek H, Chandarana H, Vivier PH, Babb JS, Diflo T, John DG, Benstein JA, Barisoni L, Stoffel DR, Lee VS.

Radiology. 2011 Sep;260(3):781-9. doi: 10.1148/radiol.11101664. Epub 2011 Jul 19.

36.

The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy.

Zhdanova O, Srivastava S, Di L, Li Z, Tchelebi L, Dworkin S, Johnstone DB, Zavadil J, Chong MM, Littman DR, Holzman LB, Barisoni L, Skolnik EY.

Kidney Int. 2011 Oct;80(7):719-30. doi: 10.1038/ki.2011.122. Epub 2011 May 4.

37.

TRPC6 enhances angiotensin II-induced albuminuria.

Eckel J, Lavin PJ, Finch EA, Mukerji N, Burch J, Gbadegesin R, Wu G, Bowling B, Byrd A, Hall G, Sparks M, Zhang ZS, Homstad A, Barisoni L, Birbaumer L, Rosenberg P, Winn MP.

J Am Soc Nephrol. 2011 Mar;22(3):526-35. doi: 10.1681/ASN.2010050522. Epub 2011 Jan 21.

38.

TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α.

Bruggeman LA, Drawz PE, Kahoud N, Lin K, Barisoni L, Nelson PJ.

Lab Invest. 2011 Mar;91(3):413-25. doi: 10.1038/labinvest.2010.199. Epub 2011 Jan 10.

39.

Cogan's syndrome and development of ANCA-associated renal vasculitis after lengthy disease remission.

Lydon EJ, Barisoni L, Belmont HM.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S144. No abstract available.

PMID:
19646364
40.

Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis.

Crowley SD, Vasievich MP, Ruiz P, Gould SK, Parsons KK, Pazmino AK, Facemire C, Chen BJ, Kim HS, Tran TT, Pisetsky DS, Barisoni L, Prieto-Carrasquero MC, Jeansson M, Foster MH, Coffman TM.

J Clin Invest. 2009 Apr;119(4):943-53. doi: 10.1172/JCI34862. Epub 2009 Mar 16.

41.

Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.

Izmirly PM, Barisoni L, Buyon JP, Kim MY, Rivera TL, Schwartzman JS, Weisstuch JM, Liu DT, Bernstein S, Tseng CE, Belmont HM, Esmon CT, Merrill JT, Askanase AD, Thomas DB, Clancy RM.

Rheumatology (Oxford). 2009 May;48(5):513-9. doi: 10.1093/rheumatology/kep034. Epub 2009 Mar 13.

42.

Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy.

Barisoni L, Schnaper HW, Kopp JB.

Arch Pathol Lab Med. 2009 Feb;133(2):201-16. doi: 10.1043/1543-2165-133.2.201.

43.

Current therapies for lupus nephritis in an ethnically heterogeneous cohort.

Rivera TL, Belmont HM, Malani S, Latorre M, Benton L, Weisstuch J, Barisoni L, Tseng CE, Izmirly PM, Buyon JP, Askanase AD.

J Rheumatol. 2009 Feb;36(2):298-305. doi: 10.3899/jrheum.080335.

PMID:
19040310
44.

Notch signaling: a common pathway of injury in podocytopathies?

Barisoni L.

J Am Soc Nephrol. 2008 Jun;19(6):1045-6. doi: 10.1681/ASN.2008040351. Epub 2008 May 14. No abstract available.

45.

VEGF inhibition and renal thrombotic microangiopathy.

Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE.

N Engl J Med. 2008 Mar 13;358(11):1129-36. doi: 10.1056/NEJMoa0707330.

46.

Current views on collapsing glomerulopathy.

Albaqumi M, Barisoni L.

J Am Soc Nephrol. 2008 Jul;19(7):1276-81. doi: 10.1681/ASN.2007080926. Epub 2008 Feb 20. Review.

47.

Collapsing glomerulopathy associated with inherited mitochondrial injury.

Barisoni L, Diomedi-Camassei F, Santorelli FM, Caridi G, Thomas DB, Emma F, Piemonte F, Ghiggeri GM.

Kidney Int. 2008 Jul;74(2):237-43. doi: 10.1038/sj.ki.5002767. Epub 2008 Jan 30. No abstract available.

48.

Acute renal failure after initiation of tenofovir disoproxil fumarate.

Hynes P, Urbina A, McMeeking A, Barisoni L, Rabenou R.

Ren Fail. 2007;29(8):1063-6.

PMID:
18067059
49.

Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease.

Cornell LD, Chicano SL, Deshpande V, Collins AB, Selig MK, Lauwers GY, Barisoni L, Colvin RB.

Am J Surg Pathol. 2007 Oct;31(10):1586-97.

PMID:
17895762
50.

COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement.

Diomedi-Camassei F, Di Giandomenico S, Santorelli FM, Caridi G, Piemonte F, Montini G, Ghiggeri GM, Murer L, Barisoni L, Pastore A, Muda AO, Valente ML, Bertini E, Emma F.

J Am Soc Nephrol. 2007 Oct;18(10):2773-80. Epub 2007 Sep 12.

Supplemental Content

Loading ...
Support Center